![](/img/cover-not-exists.png)
Erlotinib plus bevacizumab for EGFR-mutant advanced non-squamous non-small-cell lung cancer patients: ready for first-line?
Adderley, Helen, Ackermann, Christoph Jakob, Califano, RaffaeleVolume:
7
Journal:
Annals of Translational Medicine
DOI:
10.21037/atm.2019.09.116
Date:
December, 2019
File:
PDF, 162 KB
2019